These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1310 related items for PubMed ID: 30958034

  • 1. Association of Luteinizing hormone and LH receptor gene polymorphism with susceptibility of Polycystic ovary syndrome.
    Deswal R, Nanda S, Dang AS.
    Syst Biol Reprod Med; 2019 Oct; 65(5):400-408. PubMed ID: 30958034
    [Abstract] [Full Text] [Related]

  • 2. Association of luteinizing hormone chorionic gonadotropin receptor gene polymorphism (rs2293275) with polycystic ovarian syndrome.
    Thathapudi S, Kodati V, Erukkambattu J, Addepally U, Qurratulain H.
    Genet Test Mol Biomarkers; 2015 Mar; 19(3):128-32. PubMed ID: 25565299
    [Abstract] [Full Text] [Related]

  • 3. Association of the genetic variants of luteinizing hormone, luteinizing hormone receptor and polycystic ovary syndrome.
    Liu N, Ma Y, Wang S, Zhang X, Zhang Q, Zhang X, Fu L, Qiao J.
    Reprod Biol Endocrinol; 2012 Apr 30; 10():36. PubMed ID: 22546001
    [Abstract] [Full Text] [Related]

  • 4. Association between genes encoding components of the Leutinizing hormone/Luteinizing hormone-choriogonadotrophin receptor pathway and polycystic ovary syndrome in Egyptian women.
    El-Shal AS, Zidan HE, Rashad NM, Abdelaziz AM, Harira MM.
    IUBMB Life; 2016 Jan 30; 68(1):23-36. PubMed ID: 26662070
    [Abstract] [Full Text] [Related]

  • 5. Effect Modification of LHCGR Gene Variant (rs2293275) on Clinico-Biochemical Profile, and Levels of Luteinizing Hormone in Polycystic Ovary Syndrome Patients.
    Makhdoomi MJ, Shah IA, Rashid R, Rashid A, Singh S, Shah ZA, Ganie MA.
    Biochem Genet; 2023 Aug 30; 61(4):1418-1432. PubMed ID: 36633772
    [Abstract] [Full Text] [Related]

  • 6. Association analysis of LHCGR variants and polycystic ovary syndrome in Punjab: a case-control approach.
    Singh S, Kaur M, Kaur R, Beri A, Kaur A.
    BMC Endocr Disord; 2022 Dec 30; 22(1):335. PubMed ID: 36585675
    [Abstract] [Full Text] [Related]

  • 7. Preliminary study showing no association between G238A (rs361525) tumor necrosis factor-α (TNF-α) gene polymorphism and its serum level, hormonal and biochemical aspects of polycystic ovary syndrome.
    Kordestani F, Mazloomi S, Mortazavi Y, Mazloomzadeh S, Fathi M, Rahmanpour H, Nazarian A.
    BMC Med Genet; 2018 Aug 22; 19(1):149. PubMed ID: 30134857
    [Abstract] [Full Text] [Related]

  • 8. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
    Li X, Lin JF.
    Zhonghua Yi Xue Za Zhi; 2005 Dec 07; 85(46):3266-71. PubMed ID: 16409817
    [Abstract] [Full Text] [Related]

  • 9. Association of the luteinizing hormone/choriogonadotropin receptor gene polymorphism with polycystic ovary syndrome.
    Bassiouny YA, Rabie WA, Hassan AA, Darwish RK.
    Gynecol Endocrinol; 2014 Jun 07; 30(6):428-30. PubMed ID: 24592983
    [Abstract] [Full Text] [Related]

  • 10. Single-nucleotide polymorphism of INS, INSR, IRS1, IRS2, PPAR-G and CAPN10 genes in the pathogenesis of polycystic ovary syndrome.
    Thangavelu M, Godla UR, Paul Solomon FD, Maddaly R.
    J Genet; 2017 Mar 07; 96(1):87-96. PubMed ID: 28360393
    [Abstract] [Full Text] [Related]

  • 11. Clinical and metabolic characteristics of Turkish adolescents with polycystic ovary syndrome.
    Ates S, Aydın S, Ozcan P, Soyman Z, Gokmen Karasu AF, Sevket O.
    J Obstet Gynaecol; 2018 Feb 07; 38(2):236-240. PubMed ID: 28920502
    [Abstract] [Full Text] [Related]

  • 12. Genotype-phenotype correlations of PCOS susceptibility SNPs identified by GWAS in a large cohort of Han Chinese women.
    Cui L, Zhao H, Zhang B, Qu Z, Liu J, Liang X, Zhao X, Zhao J, Sun Y, Wang P, Li T, Shi Y, Chen ZJ.
    Hum Reprod; 2013 Feb 07; 28(2):538-44. PubMed ID: 23208300
    [Abstract] [Full Text] [Related]

  • 13. The plasminogen activator inhibitor-1 (PAI-1) gene -844 A/G and -675 4G/5G promoter polymorphism significantly influences plasma PAI-1 levels in women with polycystic ovary syndrome.
    Lin S, Huiya Z, Bo L, Wei W, Yongmei G.
    Endocrine; 2009 Dec 07; 36(3):503-9. PubMed ID: 19856137
    [Abstract] [Full Text] [Related]

  • 14. Association of MEP1A gene variants with insulin metabolism in central European women with polycystic ovary syndrome.
    Lam UD, Lerchbaum E, Schweighofer N, Trummer O, Eberhard K, Genser B, Pieber TR, Obermayer-Pietsch B.
    Gene; 2014 Mar 10; 537(2):245-52. PubMed ID: 24388959
    [Abstract] [Full Text] [Related]

  • 15. Relationship between leptin receptor and polycystic ovary syndrome.
    Li L, Lee KJ, Choi BC, Baek KH.
    Gene; 2013 Sep 15; 527(1):71-4. PubMed ID: 23769971
    [Abstract] [Full Text] [Related]

  • 16. [Clinical Study of the Impact of ACE I/D Gene Variation on the Clinical Parameters of Patients with Polycystic Ovary Syndrome].
    Ma WD, Fan P, Liu HW, Liu QQ, Hu KF, Bai H, Li SY.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 Sep 15; 52(5):877-882. PubMed ID: 34622609
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 66.